Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib)...

Journal of Clinical Oncology 2014 / 11 Vol. 32; Iss. 33

Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor

Johnson, D. B., Flaherty, K. T., Weber, J. S., Infante, J. R., Kim, K. B., Kefford, R. F., Hamid, O., Schuchter, L., Cebon, J., Sharfman, W. H., McWilliams, R. R., Sznol, M., Lawrence, D. P., Gibney,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2014.57.3535
Date:
November, 2014
File:
PDF, 353 KB
english, 2014
Conversion to is in progress
Conversion to is failed